Navigation Links
Diplomat Celebrates Multiple Sclerosis Week with National Campaign
Date:3/8/2016

FLINT, Mich., March 8, 2016 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today that it is celebrating Multiple Sclerosis (MS) Awareness Week with a campaign to honor patients and caregivers. The company released a video of one of its patients to tell her personal story and call attention to MS.

Meet Bethany: Multiple Sclerosis

Diplomat Specialty Pharmacy (PRNewsFoto/Diplomat Pharmacy, Inc.)
Diplomat Specialty Pharmacy (PRNewsFoto/Diplomat Pharmacy, Inc.)

MS Awareness Week is celebrated to raise visibility of multiple sclerosis and the impact on patients' lives. Multiple sclerosis is an unpredictable, often disabling disease of the central nervous system and interrupts the flow of information within the brain, and between the brain and body. Symptoms range from numbness and tingling, to blindness, paralysis and cognitive difficulties. According to the National Multiple Sclerosis Society, most people diagnosed with MS are between the ages of 20 and 50, with at least two to three times more women than men being diagnosed with the disease.

"The real-life story of Bethany reveals the true spirit of the Diplomat Difference and the critical role that specialty pharmacy plays in managing some of the nation's most complex patient cases," said Diplomat CEO and Chairman Phil Hagerman. "At Diplomat, we're committed to not only provide high-touch care through our specially designed programs, but also listen to patient stories and share their victories, whether they be large or small."

Forward-Looking Statements

This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements give current expectations or forecasts of future events or our future financial or operating performance. The forward-looking statements contained in this press release are based on management's good-faith belief and reasonable judgment based on current information. These statements are qualified by important risks and uncertainties, many of which are beyond our control, that could cause our actual results to differ materially from those forecasted or indicated by such forward-looking statements. For a discussion of such risks and uncertainties, you should review Diplomat's filings with the Securities and Exchange Commission, including "Risk Factors" in Diplomat's Annual Report on Form 10-K for the year ended December 31, 2015 and in subsequent reports filed with or furnished to the Securities and Exchange Commission. Except as may be required by any applicable laws, Diplomat assumes no obligation to publicly update such forward-looking statements, which are made as of the date hereof or the earlier date specified herein, whether as a result of new information, future developments or otherwise.

About Diplomat

Diplomat (NYSE: DPLO) serves patients and physicians in all 50 states. Headquartered in Flint, Michigan, the company focuses on medication management programs for people with complex chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, specialized infusion therapy and many other serious or long-term conditions. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: "Take good care of patients, and the rest falls into place." Today, that tradition continues—always focused on improving patient care and clinical adherence. For more information visit www.diplomat.is. Follow us on Twitter and LinkedIn and like us on Facebook.

CONTACT:
Kali Lucas, Public Relations Coordinator 
810.768.9580 | press@diplomat.is 

Logo - http://photos.prnewswire.com/prnh/20140928/148820 


'/>"/>
SOURCE Diplomat Pharmacy, Inc.
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Diplomats Amy Clarke Elected as President of Immunoglobulin National Society
2. Diplomat Launches Pharmacy Tech Certification Program
3. Diplomat Announces Executive Promotions for Kaddis and Neill
4. Diplomat to Participate in the Raymond James & Associates 37th Annual Institutional Investors Conference
5. Diplomat to Release Fourth Quarter and Year End Operating Results and Host Conference Call on Monday, February 29, 2016
6. Diplomat Announces Executive Promotion for Paul Urick
7. Diplomats President Elected as Board Chair for American Foundation for Pharmaceutical Education
8. Diplomat to Participate in the 34th Annual J.P. Morgan Healthcare Conference
9. Diplomat Receives Full URAC Specialty Pharmacy Reaccreditation
10. Diplomat Launches New COE Program to Focus on Rare-Disease Populations
11. Diplomat Named Among Top 100 Places to Work by Detroit Free Press
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing ... of targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek ...
(Date:9/18/2017)... PROVIDENCE, R.I. , Sept. 18, 2017 ... in the fields of bioinformatics and immune ... to develop a protective avian influenza A (H7N9) vaccine. ... is distantly related to seasonal influenza and ... approaches, which rely on prior exposure to be ...
Breaking Medicine Technology:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Many families ... However, many long-term care insurance companies have a waiver for care if the client ... elimination period, when the family pays for care, is often waived, so the benefits ...
(Date:10/13/2017)... ... ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out many kids ... sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting kids excited ... all ages; it is a non-competitive, non-timed event, which is all about having fun ...
(Date:10/13/2017)... Fairfax, VA (PRWEB) , ... October 13, 2017 ... ... provider of DevOps and Agile Software Development, has been awarded a contract by ... (EATS) Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile ...
(Date:10/12/2017)... WILMINGTON, Del. (PRWEB) , ... October 12, 2017 ... ... technology and advisory services for healthcare compliance program management, will showcase a range ... and National Association for Assisted Living (NCAL) Convention and Expo to be held ...
(Date:10/12/2017)... WAUSAU, Wis. (PRWEB) , ... October 12, 2017 ... ... formulated standard products to meet the demand of today’s consumer and regulatory authorities ... team of probiotic experts and tested to meet the highest standard. , ...
Breaking Medicine News(10 mins):